Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_assertion type Assertion NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_head.
- NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_assertion description "[Large studies on variants in some androgen-metabolizing genes [SRD5A2, CYP17A1, and hydroxysteroid dehydrogenase (HSD)17B1] do not show a convincing links to prostate cancer, though there are insufficient data to draw conclusions on other genes related to androgen metabolism, including UDP-glycosyltransferases (UGT), sulfotransferases (SULT), CYP3A, and estrogen-related genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_provenance.
- NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_assertion evidence source_evidence_literature NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_provenance.
- NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_assertion SIO_000772 18438175 NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_provenance.
- NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_assertion wasDerivedFrom befree-20140225 NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_provenance.
- NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_assertion wasGeneratedBy ECO_0000203 NP518631.RAxx4J4x-xgL1Hw6tILLwlcbegrjGSvo1QbfPD_DouIlY130_provenance.